{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-278158","form_type":"8-K","ticker":"XAGE","cik":"0001842939","company_name":"Longevity Health Holdings, Inc.","filed_at":"2023-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.971713+00:00","generated_at":"2026-06-08T01:25:57.771570+00:00","sec_items":["5.02","7.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Carmell appoints Scott Frisch (AARP COO/CFO) and Gilles Spenlehauer as independent directors","bullets":["Scott Frisch, COO/CFO of AARP, joins audit committee.","Gilles Spenlehauer, Scientific Director at SDTech, ex-L'Oreal research head, joins nominating committee.","Both directors are independent under Nasdaq rules and serve as Class II until 2024 annual meeting.","Compensation committee unchanged; no arrangements or transactions requiring disclosure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-278158","json":"https://secwatch.observer/filing/0001193125-23-278158.json","markdown":"https://secwatch.observer/filing/0001193125-23-278158.md","text":"https://secwatch.observer/filing/0001193125-23-278158.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523278158/0001193125-23-278158-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523278158/d945740d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T01:25:57.771570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e2be1c9e5c","claim":"Gilles Spenlehauer was appointed as Director at Longevity Health Holdings, Inc..","evidence_excerpt":"the Board appointed Scott Frisch and Gilles Spenlehauer (collectively, the “New Directors”) to serve as directors on the Board of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523278158/0001193125-23-278158-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"eda5773f1f","claim":"Scott Frisch was appointed as Director at Longevity Health Holdings, Inc..","evidence_excerpt":"the Board appointed Scott Frisch and Gilles Spenlehauer (collectively, the “New Directors”) to serve as directors on the Board of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1842939/000119312523278158/0001193125-23-278158-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}